Larvol Delta - Cognition-Therapeutics-Announces-Positive-Results-in-Phase-2-Study-of-CT1812-in-Dementia-with-Lewy-Bodies

Elayta (CT1812) - Cognition Therap

https://www.globenewswire.com/news-release/2024/12/18/2998947/0/en/Cognition-Therapeutics-Announces-Positive-Results-in-Phase-2-Study-of-CT1812-in-Dementia-with-Lewy-Bodies.html

Dec 18, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next